Literature DB >> 33037123

Rhabdomyolysis as the Initial Presentation of SARS-CoV-2 in an Adolescent.

Shawnese Gilpin1, Michael Byers2, Allison Byrd2, Jennifer Cull3, Danielle Peterson3, Bettina Thomas2, Phillip Jacobson2,4.   

Abstract

The novel coronavirus disease 2019, caused by severe acute respiratory syndrome coronavirus 2, has created a global pandemic, with many cases affecting the elderly. However, children have been affected as well, with ∼2.4% to 3.7% of cases reported. This case is the first published case of an adolescent presenting with rhabdomyolysis as the first sign of novel coronavirus disease 2019, with extremely elevated creatinine kinase levels, approaching almost 400 000 U/L. This case adds to the growing body of literature of a variety of life-threatening manifestations associated with severe acute respiratory syndrome coronavirus 2 infection and highlights the importance of how prompt recognition of these unique presentations of the disease is important to mitigate complications.
Copyright © 2021 by the American Academy of Pediatrics.

Entities:  

Year:  2020        PMID: 33037123     DOI: 10.1542/peds.2020-019273

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  3 in total

1.  Rhabdomyolysis and coronavirus disease-2019 in children: A case report and review of the literature.

Authors:  Maria Kontou; Konstantinos Kakleas; Vaso Kimioni; Dimitra Georgiadi; Vasiliki Spoulou; Athanasios Michos
Journal:  Pediatr Investig       Date:  2022-04-01

Review 2.  Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease.

Authors:  Jaime Silva; Felipe Patricio; Aleidy Patricio-Martínez; Gerardo Santos-López; Lilia Cedillo; Yousef Tizabi; Ilhuicamina Daniel Limón
Journal:  Front Neurosci       Date:  2022-05-03       Impact factor: 5.152

Review 3.  A Comprehensive Review of Neuromuscular Manifestations of COVID-19 and Management of Pre-Existing Neuromuscular Disorders in Children.

Authors:  Daniel J Goetschius; Yunsung Kim; Ashutosh Kumar; Dustin Paul; Sunil Naik
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.